Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ORGO · against 557 other Healthcare companies listed in US-listed
Ranked #306 of 558 · scores higher than 44% of peers
Bars: peers in each 10-point band of the profitability score82 peers with a profitability score of 20–29, including ORGO · Click a bar to see the companies
Mainly because of its return on invested capital, return on assets and operating margin, which are weaker than most Healthcare peers.
| Metric | ORGO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 517 reported | -27.7% | -7.0% | 36% | 33% | |
| Operating marginHigher is better · 479 reported | -7.8% | -2.4% | 45% | 33% | |
| Return on assetsHigher is better · 582 reported | -20.7% | -7.8% | 37% | 33% | |
| Return on equityHigher is better · 531 reported | -25.9% | -19.7% | 47% | Context only | |
| Gross marginHigher is better · 601 reported | 71.5% | 43.9% | 75% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 17.9B USD | 99 | 76 | |
| 1 | 52.9B USD | 99 | 57 | |
| 1 | 578M USD | 99 | 73 | |
| 298 | 2.0B USD | 24 | 42 | |
| 306 | 471M USD | 23 | 21 | |
| 306 | 4.2B USD | 23 | 44 | |
| 306 | 469M USD | 23 | 50 | |
| 306 | 107M USD | 23 | 26 | |
| 306 | 9.0B USD | 23 | 33 | |
| 306 | 595M USD | 23 | 29 | |
| 312 | 2.2B USD | 22 | 32 | |
| 312 | 110M USD | 22 | 38 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score